Genocea Biosciences Yönetim
Yönetim kriter kontrolleri 2/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Chip Clark
İcra Kurulu Başkanı
US$3.8m
Toplam tazminat
CEO maaş yüzdesi | 15.2% |
CEO görev süresi | 12.3yrs |
CEO sahipliği | n/a |
Yönetim ortalama görev süresi | 7.3yrs |
Yönetim Kurulu ortalama görev süresi | 8.7yrs |
Son yönetim güncellemeleri
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet
Jun 17What Type Of Returns Would Genocea Biosciences'(NASDAQ:GNCA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 18How Much Of Genocea Biosciences, Inc. (NASDAQ:GNCA) Do Institutions Own?
Jan 14CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Mar 31 2022 | n/a | n/a | -US$37m |
Dec 31 2021 | US$4m | US$571k | -US$33m |
Sep 30 2021 | n/a | n/a | -US$35m |
Jun 30 2021 | n/a | n/a | -US$36m |
Mar 31 2021 | n/a | n/a | -US$43m |
Dec 31 2020 | US$1m | US$551k | -US$44m |
Sep 30 2020 | n/a | n/a | -US$38m |
Jun 30 2020 | n/a | n/a | -US$41m |
Mar 31 2020 | n/a | n/a | -US$36m |
Dec 31 2019 | US$1m | US$533k | -US$39m |
Sep 30 2019 | n/a | n/a | -US$29m |
Jun 30 2019 | n/a | n/a | -US$30m |
Mar 31 2019 | n/a | n/a | -US$27m |
Dec 31 2018 | US$1m | US$515k | -US$28m |
Sep 30 2018 | n/a | n/a | -US$39m |
Jun 30 2018 | n/a | n/a | -US$48m |
Mar 31 2018 | n/a | n/a | -US$59m |
Dec 31 2017 | US$2m | US$493k | -US$57m |
Sep 30 2017 | n/a | n/a | -US$62m |
Jun 30 2017 | n/a | n/a | -US$58m |
Mar 31 2017 | n/a | n/a | -US$54m |
Dec 31 2016 | US$1m | US$455k | -US$50m |
Tazminat ve Piyasa: Chip's total compensation ($USD3.75M) is above average for companies of similar size in the US market ($USD740.57K).
Tazminat ve Kazançlar: Chip's compensation has increased whilst the company is unprofitable.
CEO
Chip Clark (53 yo)
12.3yrs
Görev süresi
US$3,750,857
Tazminat
Mr. William D. Clark, M.B.A., also known as Chip, has been an Independent Director at iBio, Inc. since August 26, 2021 and serves as its Chairman since November 2022. He has been the Director, Chief Execut...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 12.3yrs | US$3.75m | Veri yok | |
Chief Scientific Officer | 7.3yrs | US$1.27m | Veri yok | |
CFO & Secretary | 4.2yrs | Veri yok | Veri yok |
7.3yrs
Ortalama Görev Süresi
50yo
Ortalama Yaş
Deneyimli Yönetim: GNCA.Q's management team is seasoned and experienced (7.3 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 12.3yrs | US$3.75m | Veri yok | |
Independent Chairman of the Board | 8.7yrs | US$120.98k | Veri yok | |
Independent Director | 8.3yrs | US$78.48k | Veri yok | |
Independent Director | 10.2yrs | US$75.88k | Veri yok | |
Independent Chairman of Scientific Advisory Board & Director | 16.3yrs | US$66.98k | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Independent Director | 1.7yrs | US$61.50k | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Independent Director | 1.2yrs | Veri yok | Veri yok |
8.7yrs
Ortalama Görev Süresi
53.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: GNCA.Q's board of directors are considered experienced (8.7 years average tenure).